AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)
Authors: Skarlos, DV Samantas, E Briassoulis, E Panoussaki, E Pavlidis, N Kalofonos, HP Kardamakis, D Tsiakopoulos, E Kosmidis, P Tsavdaridis, D Tzitzikas, J Tsekeris, P Kouvatseas, G Zamboglou, N Fountzilas, G
Citation: Dv. Skarlos et al., Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG), ANN ONCOL, 12(9), 2001, pp. 1231-1238
Paclitaxel: Epirubicin in metastatic breast cancer - a review
Authors: Razis, ED Fountzilas, G
Citation: Ed. Razis et G. Fountzilas, Paclitaxel: Epirubicin in metastatic breast cancer - a review, ANN ONCOL, 12(5), 2001, pp. 593-598
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer - A Hellenic Cooperative Oncology Group phase IIstudy
Authors: Fountzilas, G Tsavdaridis, D Kalogera-Fountzila, A Christodoulou, C Timotheadou, E Kalofonos, C Kosmidis, P Adamou, A Papakostas, P Gogas, H Stathopoulos, G Razis, E Bafaloukos, D Skarlos, D
Citation: G. Fountzilas et al., Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer - A Hellenic Cooperative Oncology Group phase IIstudy, ANN ONCOL, 12(11), 2001, pp. 1545-1551
Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer
Authors: Razis, E Dimopoulus, AM Bafaloukos, D Papadimitriou, C Kalogera-Fountzila, A Kalofonos, H Briassoulis, E Samantas, E Keramopoulos, A Pavlidis, N Kosmidis, P Fountzilas, G
Citation: E. Razis et al., Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer, CANCER INV, 19(2), 2001, pp. 137-144
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the Hellenic Cooperative Oncology Group
Authors: Fountzilas, G Papadimitriou, C Dafni, U Bafaloukos, D Skarlos, D Moulopouos, LA Razis, E Kalofonos, HP Aravantinos, G Briassoulis, E Papakostas, P Abela, K Gogas, E Kosmidis, P Pavlidis, N Dimopoulos, MA
Citation: G. Fountzilas et al., Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the Hellenic Cooperative Oncology Group, J CL ONCOL, 19(8), 2001, pp. 2232-2239
Angiogenesis and apoptosis-related protein (p53, bcl-2, and bax) expression versus response of gastric adenocarcinomas to paclitaxel and carboplatin chemotherapy
Authors: Giatromanolaki, A Stathopoulos, GP Koukourakis, MI Rigatos, S Vrettou, E Kittas, C Fountzilas, G Sivridis, E
Citation: A. Giatromanolaki et al., Angiogenesis and apoptosis-related protein (p53, bcl-2, and bax) expression versus response of gastric adenocarcinomas to paclitaxel and carboplatin chemotherapy, AM J CL ONC, 24(3), 2001, pp. 222-226
An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic Co-Operative Oncology Group
Authors: Pectasides, D Kalofonos, HP Samantas, E Nicolaides, C Papacostas, P Onyenadum, A Visvikis, A Skarlos, D Fountzilas, G
Citation: D. Pectasides et al., An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic Co-Operative Oncology Group, ANTICANC R, 21(4B), 2001, pp. 3005-3010
Bax protein expression in colorectal cancer: Association with p53, bcl-2 and patterns of relapse
Authors: Giatromanolaki, A Sivridis, E Stathopoulos, GP Fountzilas, G Kalofonos, HP Tsamandas, A Vrettou, E Scopa, C Polychronidis, A Simopoulos, K Koukourakis, MI
Citation: A. Giatromanolaki et al., Bax protein expression in colorectal cancer: Association with p53, bcl-2 and patterns of relapse, ANTICANC R, 21(1A), 2001, pp. 253-259
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer
Authors: Fountzilas, G Papadimitriou, C Aravantinos, G Nicolaides, C Stathopoulos, G Bafaloukos, D Kalofonos, H Ekonomopoulos, T Skarlos, D Pavlidis, N Dimopoulos, AM
Citation: G. Fountzilas et al., Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer, ONCOL-BASEL, 60(3), 2001, pp. 214-220
Combined chemoradiotherapy in locally advanced nasopharyngeal carcinoma
Authors: Daniilidis, J Constantinidis, J Fountzilas, G
Citation: J. Daniilidis et al., Combined chemoradiotherapy in locally advanced nasopharyngeal carcinoma, HNO, 49(9), 2001, pp. 732-738
G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant setting
Authors: Briasoulis, E Andreopoulou, E Tolis, CF Bairaktari, E Katsaraki, A Dimopoulos, MA Fountzilas, G Seferiadis, G Pavlidis, N
Citation: E. Briasoulis et al., G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant setting, CANCER, 91(5), 2001, pp. 909-917
Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy
Authors: Koukourakis, MI Giatromanolaki, A Fountzilas, G Sivridis, E Gatter, KC Harris, AL
Citation: Mi. Koukourakis et al., Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy, CLIN CANC R, 6(2), 2000, pp. 381-389
Paclitaxel (175 mg/m(2)) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m(2))plus carboplatin (6 AUG) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial
Authors: Kosmidis, P Mylonakis, N Skarlos, D Samantas, E Dimopoulos, M Papadimitriou, C Kalophonos, C Pavlidis, N Nikolaidis, C Papaconstantinou, C Fountzilas, G
Citation: P. Kosmidis et al., Paclitaxel (175 mg/m(2)) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m(2))plus carboplatin (6 AUG) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial, ANN ONCOL, 11(7), 2000, pp. 799-805
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group
Authors: Nicolaides, C Dimopoulos, MA Samantas, E Bafaloukos, D Kalofonos, C Fountzilas, G Razi, E Kosmidis, P Pavlidis, N
Citation: C. Nicolaides et al., Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 11(7), 2000, pp. 873-875
Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study
Authors: Janinis, J Papakostas, P Samelis, G Skarlos, D Papagianopoulos, P Fountzilas, G
Citation: J. Janinis et al., Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study, ANN ONCOL, 11(2), 2000, pp. 163-167
Phase II study of pegylated liposomal doxorubicin: Inactive in recurrent small-cell lung cancer - A Hellenic Cooperative Oncology Group Study
Authors: Samantas, E Kalofonos, H Linardou, H Nicolaides, C Mylonakis, N Fountzilas, G Kosmidis, P Skarlos, D
Citation: E. Samantas et al., Phase II study of pegylated liposomal doxorubicin: Inactive in recurrent small-cell lung cancer - A Hellenic Cooperative Oncology Group Study, ANN ONCOL, 11(11), 2000, pp. 1395-1397
Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: A Hellenic cooperative oncology group phase II study
Authors: Fountzilas, G Nicolaides, C Bafaloukos, D Kalogera-Fountzila, A Kalofonos, H Samelis, G Aravantinos, G Pavlidis, N
Citation: G. Fountzilas et al., Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: A Hellenic cooperative oncology group phase II study, CANCER INV, 18(6), 2000, pp. 503-509
Carboplatin plus paclitaxel in unknown primary carcinoma: A phase II Hellenic Cooperative Oncology Group study
Authors: Briasoulis, E Kalofonos, H Bafaloukos, D Samantas, E Fountzilas, G Xiros, N Skarlos, D Christodoulou, C Kosmidis, F Pavlidis, N
Citation: E. Briasoulis et al., Carboplatin plus paclitaxel in unknown primary carcinoma: A phase II Hellenic Cooperative Oncology Group study, J CL ONCOL, 18(17), 2000, pp. 3101-3107
A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study
Authors: Janinis, J Giannakakis, T Athanasiades, A Fountzilas, G Bafaloukos, D Kosmidis, P Nikolaides, K Pavlidis, N Skarlos, D
Citation: J. Janinis et al., A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study, TUMORI, 86(1), 2000, pp. 37-41
Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas
Authors: Giatromanolaki, A Koukourakis, MI Sivridis, E Thorpe, PE Brekken, RA Konstantinos, S Fountzilas, G Gatter, KC Harris, AL
Citation: A. Giatromanolaki et al., Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas, CLIN EXP M, 18(4), 2000, pp. 313-319
c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cellcarcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival
Authors: Giatromanolaki, A Ourakis, MIK Sivridis, E Fountzilas, G
Citation: A. Giatromanolaki et al., c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cellcarcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival, ANTICANC R, 20(2A), 2000, pp. 997-1004
Burkitt's lymphoma in Greek adults - A study of the Hellenic co-operative oncology group
Authors: Economopoulos, T Dimopoulos, MA Foudoulakis, A Nikolaidis, C Tsatalas, C Pectacides, D Rontogianni, D Papageorgiou, E Fountzilas, G
Citation: T. Economopoulos et al., Burkitt's lymphoma in Greek adults - A study of the Hellenic co-operative oncology group, LEUK RES, 24(12), 2000, pp. 993-998
Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: A phase III randomized study. Preliminary results
Authors: Kosmidis, P Mylonakis, N Dimopoulos, A Pavlidis, N Fountzilas, G Samantas, E Dimitriadis, K Kalophonos, C Tsavdaridis, D Skarlos, D
Citation: P. Kosmidis et al., Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: A phase III randomized study. Preliminary results, SEMIN ONCOL, 27(1), 2000, pp. 3-8
Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: The Hellenic Cooperative Oncology Group experience
Authors: Pectasides, D Economopoulos, T Kouvatseas, G Antoniou, A Zoumbos, Z Aravantinos, G Tsatalas, C Halikia, A Nikolaides, C Kiamouris, C Pappa, E Pavlidis, N Skarlos, D Fountzilas, G Dimopoulos, MA
Citation: D. Pectasides et al., Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: The Hellenic Cooperative Oncology Group experience, ONCOL-BASEL, 58(4), 2000, pp. 286-292
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvanttreatment, in patients with high-risk colon cancer - A randomized phase III study conducted by the Hellenic Cooperative Oncology Group
Authors: Fountzilas, G Zisiadis, A Dafni, U Konstantaras, C Hatzitheoharis, G Papavramidis, S Bousoulegas, A Basdanis, G Giannoulis, E Dokmetzioglou, J Katsohis, C Nenopoulou, E Karvounis, N Briassoulis, E Aravantinos, G Kosmidis, P Skarlos, D Pavlidis, N
Citation: G. Fountzilas et al., Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvanttreatment, in patients with high-risk colon cancer - A randomized phase III study conducted by the Hellenic Cooperative Oncology Group, ONCOL-BASEL, 58(3), 2000, pp. 227-236
Risultati: 1-25 | 26-42